MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/sexmed/qfag092

Медицинская библиотека · Sexual medicine · 2026

The effect of Bartholin gland diseases on female sexual function, sexual distress, and genital self-image: a prospective cohort study.

Dağıstanlı Funda, Yıldız Pınar Fatma, Şafak İhsan, Ekici Mustafa Ayhan

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Bartholin gland disease impairs sexual function, yet most studies focus on surgical technique rather than the broader sexual health burden, and none has systematically examined sexual distress or genital self-image in this population. We aimed to characterize the sexual health burden of Bartholin gland disease across four domains: pain (Visual Analogue Scale [VAS]), sexual function (Female Sexual Function Index [FSFI]), sexual distress (Female Sexual Distress Scale-Revised [FSDS-R]), and genital self-image (Female Genital Self-Image Scale [FGSIS]), at two time points (before and after treatment) and to compare findings against matched healthy controls.

METHODS

This prospective cohort study enrolled 25 women diagnosed with a Bartholin gland cyst or abscess (patient group) and 25 age-matched healthy controls at a single training and research hospital. Patients were evaluated twice: at presentation before any treatment (T1) and after symptom resolution (T2). Controls were assessed once. Outcome measures were the VAS (applied to patients only), FSFI (cut-off <26.55), FSDS-R (cut-off ≥11), and FGSIS. Sample size was calculated a priori (d = 0.80, α = 0.05, power = 80%; G*Power 3.1).

RESULTS AND DISCUSSION: Groups were comparable for age (36.1 ± 6.6 vs. 34.2 ± 7.6 years, P = .472), body mass index (BMI), and parity. At T1, 48.0% of patients had clinically significant sexual dysfunction (FSFI <26.55) and 16.0% met the distress threshold (FSDS-R ≥ 11). All four scales improved significantly from T1 to T2 (P < .001 for each). By T2, FSFI (31.72 ± 3.34 vs. 31.11 ± 1.87, P = .187), FSDS-R (1.44 ± 1.69 vs. 0.56 ± 0.65, P = .068), and FGSIS (24.40 ± 2.33 vs. 23.20 ± 1.94, P = .066) no longer differed from controls. Notably, FGSIS was already similar between patients and controls at T1 (22.92 ± 3.28 vs. 23.20 ± 1.94, P = .784). VAS pain scores fell from 5.96 ± 2.64 to 1.04 ± 0.20 (effect size dz = 1.906). T1 FSFI scores did not differ by pathology type (cyst vs. abscess, P = .479) or surgical procedure (P = .866). Strong correlations were observed between FSFI and FSDS-R (r = -0.829, P < .001) and between VAS and FSDS-R (r = +0.561, P = .004). Bartholin gland disease carries a measurable sexual health burden that substantially resolves after treatment. Genital self-image appears to remain intact even during active disease. Systematic screening with FSFI and FSDS-R should be integrated into routine management; surgical decision-making should account for the higher dyspareunia risk associated with marsupialization.

Для цитирования: Dağıstanlı Funda, Yıldız Pınar Fatma, Şafak İhsan, Ekici Mustafa Ayhan. The effect of Bartholin gland diseases on female sexual function, sexual distress, and genital self-image: a prospective cohort study.. Sexual medicine. 2026. DOI: 10.1093/sexmed/qfag092.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.